scispace - formally typeset
D

Deborah Donnell

Researcher at Fred Hutchinson Cancer Research Center

Publications -  231
Citations -  13344

Deborah Donnell is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Pre-exposure prophylaxis & Population. The author has an hindex of 49, co-authored 199 publications receiving 11097 citations. Previous affiliations of Deborah Donnell include University of California, Los Angeles & University of Washington.

Papers
More filters
Posted ContentDOI

Characteristics of Kenyan Women Enrolled in a Trial on Doxycycline Post-exposure Prophylaxis for Sexually Transmitted Infection Prevention

TL;DR: Young cisgender women using HIV PrEP in Kenya and enrolled in the first trial to determine the efficacy of doxycycline post-exposure prophylaxis (PEP) to reduce STI incidence had a high prevalence of curable STIs and represent a target population for an STI prevention intervention.
Posted ContentDOI

Adaptive time location sampling for compass, a sars-cov-2 prevalence study in fifteen diverse communities in the united states

TL;DR: In this paper , the authors used time-location sampling (TLS) using complex sampling involving stratification, clustering of units, and unequal probabilities of selection was used to recruit individuals from neighborhoods in selected communities.
Journal ArticleDOI

Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection

TL;DR: In this paper , the authors evaluated the impact of a combination prevention package on population-level HIV incidence in 21 study communities in Zambia and South Africa using data from the HIV Prevention Trials Network (HPTN) 071 (PopART) study and found no significant difference in the uptake of VMMC in communities receiving the PopART intervention package and standard of care.
Journal ArticleDOI

Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)

TL;DR: In this paper , the authors evaluated ART uptake in a trial in Zambia and South Africa that implemented a community-wide universal testing and treatment package to reduce HIV incidence, which was defined as detection of ≥ 1 ARV drug.